Shanghai Hile Bio-Technology Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000022T4
CNY
7.06
0.26 (3.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
267.12
237.58
296.66
343.79
256.86
275.45
252.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
267.12
237.58
296.66
343.79
256.86
275.45
252.05
Raw Material Cost
115.93
123.02
140.48
171.08
153.07
167.11
130.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
75.09
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.50
5.42
10.35
12.53
17.75
18.24
14.96
Selling and Distribution Expenses
110.84
93.96
103.08
122.97
102.97
93.99
103.45
Other Expenses
1.59
1.71
1.56
-6.37
0.71
0.25
0.34
Total Expenditure (Excl Depreciation)
248.21
239.53
269.54
318.01
280.87
281.86
252.74
Operating Profit (PBDIT) excl Other Income
18.9
-2
27.1
25.8
-24
-6.4
-0.7000000000000001
Other Income
199.46
74.97
58.00
29.93
27.86
40.79
18.07
Operating Profit (PBDIT)
255.15
107.34
125.60
112.19
58.10
93.15
70.92
Interest
5.50
5.42
10.35
12.53
17.75
18.24
14.96
Exceptional Items
-13.89
-16.52
57.68
8.28
1.62
0.00
-0.05
Gross Profit (PBDT)
151.20
114.56
156.18
172.71
103.79
108.34
121.06
Depreciation
39.26
40.87
49.65
61.46
67.68
67.61
61.71
Profit Before Tax
196.50
44.53
123.28
46.48
-25.70
7.30
-5.79
Tax
26.48
6.01
20.53
11.47
8.81
33.24
12.48
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
171.18
62.87
121.61
53.86
8.93
12.15
21.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
171.18
62.87
121.61
53.86
8.93
12.15
21.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
10.46
-12.86
-10.92
-8.19
-41.08
-38.56
-35.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
181.64
50.01
110.69
45.67
-32.15
-26.41
-13.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,560.48
1,216.98
1,140.33
1,005.61
1,058.33
1,060.81
1,055.10
Earnings per share (EPS)
0.26
0.1
0.19
0.08
0.01
0.02
0.03
Diluted Earnings per share
0.26
0.1
0.19
0.08
0.01
0.02
0.03
Operating Profit Margin (Excl OI)
6.15%
-3.58%
6.05%
6.05%
-14.58%
-5.54%
-3.52%
Gross Profit Margin
88.26%
35.95%
58.29%
31.4%
16.34%
27.19%
22.19%
PAT Margin
64.08%
26.46%
40.99%
15.67%
3.48%
4.41%
8.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 12.42% vs -19.92% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 263.20% vs -54.83% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 71.91% vs -52.07% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 1.85% vs -48.08% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shanghai Hile Bio-Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
267.12
0
267.12
Other Operating Income
0.00
0.00
0.00
Total Operating income
267.12
0
267.12
Raw Material Cost
115.93
0
115.93
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.50
0
5.50
Selling and Distribution Expenses
110.84
0
110.84
Other Expenses
1.59
0.00
1.59
Total Expenditure (Excl Depreciation)
248.21
0
248.21
Operating Profit (PBDIT) excl Other Income
18.92
0.00
18.92
Other Income
199.46
0
199.46
Operating Profit (PBDIT)
255.15
0
255.15
Interest
5.50
0
5.50
Exceptional Items
-13.89
0
-13.89
Gross Profit (PBDT)
151.20
0
151.20
Depreciation
39.26
0
39.26
Profit Before Tax
196.50
0
196.50
Tax
26.48
0
26.48
Provisions and contingencies
0
0
0.00
Profit After Tax
171.18
0
171.18
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
171.18
0
171.18
Share in Profit of Associates
0
0
0.00
Minority Interest
10.46
0
10.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
181.64
0
181.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,560.48
0
1,560.48
Earnings per share (EPS)
0.26
0
0.26
Diluted Earnings per share
0.26
0
0.26
Operating Profit Margin (Excl OI)
6.15%
0%
0.00
6.15%
Gross Profit Margin
88.26%
0%
0.00
88.26%
PAT Margin
64.08%
0%
0.00
64.08%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 26.71 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 12.42% vs -19.92% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 18.16 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 263.20% vs -54.83% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 71.91% vs -52.07% in Dec 2023

Annual - Interest
Interest 0.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.85% vs -48.08% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.15%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023